MAPT and Alzheimer disease: Alzheimer’s disease (AD) induces profound circadian disruption—characterized by suprachiasmatic nucleus (SCN) degeneration, Aβ and tau pathology, and aberrant melatonin secretion which results in fragmented sleep–wake cycles and cognitive decline.